This CTD dossier owner and manufacturer, operating for over four decades in Southeast Asia, focuses on producing high-quality medicines to serve the local market. Their commitment to quality is reflected in their GMP-certified facilities for oral solid and liquid dosage forms. They are known for their extensive distribution network across the region, ensuring their products reach a wide customer base. While not publicly disclosing specific therapy areas, their focus appears to be on meeting the diverse health needs of the Indonesian population. With a dedicated research and development department, they strive to develop innovative and effective formulations, contributing to a healthier future for the community.